mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.1 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |